183 related articles for article (PubMed ID: 2904317)
1. [Famotidine treatment of patients with gastric and duodenal ulcers. A comparative study with once or twice-a-day administration].
Bonardelli P; Fujita Y; Fujita R; Sugata F
Clin Ter; 1987 Aug; 122(3):183-7. PubMed ID: 2904317
[No Abstract] [Full Text] [Related]
2. [H2 blockers in the treatment of bleeding gastroduodenal ulcers].
Nikiforov PA; Bazarova MA; Nikitina SA; Osin VL; Shugurov VA
Khirurgiia (Mosk); 2001; (10):49-50. PubMed ID: 11763821
[No Abstract] [Full Text] [Related]
3. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
4. Famotidine in the USA: a review of efficacy studies.
Gitnick G
J Int Med Res; 1989; 17 Suppl 1():17A-24A. PubMed ID: 2566539
[TBL] [Abstract][Full Text] [Related]
5. Famotidine in the treatment of duodenal ulcers resistant to other histamine H2-receptor antagonists.
Chen PH; Wang TH; Wang CY; Chen CY; Cheng TC; Tsai YT; Siauw CP; Yang KC; Chen GH; Sung JL
J Int Med Res; 1989; 17 Suppl 1():25A-31A. PubMed ID: 2566541
[TBL] [Abstract][Full Text] [Related]
6. A single nocte dose of famotidine in the treatment of duodenal ulcer.
Qureshi H; Ahmad W; Zuberi SJ
J Pak Med Assoc; 1989 Apr; 39(4):104-6. PubMed ID: 2568508
[TBL] [Abstract][Full Text] [Related]
7. [Famotidin (quamatel) in the treatment of gastroduodenal ulcer].
Pleshkov VG; Afanas'ev VN; Ovsiankin AV
Khirurgiia (Mosk); 2000; (6):48-9. PubMed ID: 10900844
[No Abstract] [Full Text] [Related]
8. Healing-promoting action of the new histamine H2-receptor antagonist N-ethyl-N'-[3-[3-(piperidinomethyl)phenoxy]propyl]urea with dual action on chronic gastric and duodenal ulcers induced by acetic acid in rats.
Sekiguchi H; Hamada K; Aijima H; Taga F; Uchida H; Nishino K
Arzneimittelforschung; 1993 Feb; 43(2):139-43. PubMed ID: 8096134
[TBL] [Abstract][Full Text] [Related]
9. [Acute treatment of duodenal ulcer. Results of an open multicenter study with famotidine nocte].
Schönekäs H
Fortschr Med; 1988 May; 106(14):304-6. PubMed ID: 3042560
[No Abstract] [Full Text] [Related]
10. Effects of three H2-receptor antagonists (cimetidine, famotidine, ranitidine) on serum gastrin level.
Ohsawa T; Hirata W; Higichi S
Int J Clin Pharmacol Res; 2002; 22(2):29-35. PubMed ID: 12503773
[TBL] [Abstract][Full Text] [Related]
11. [Acute therapy of duodenal ulcer. Comparison of famotidine and ranitidine in a single evening dose].
Kimmig JM
Fortschr Med; 1987 Feb; 105(5):72-6. PubMed ID: 3549493
[No Abstract] [Full Text] [Related]
12. Stability of famotidine in commonly used nutritional infusion fluids.
Underberg WJ; Koomen JM; Beijnen JH
J Parenter Sci Technol; 1988; 42(3):94-7. PubMed ID: 2905734
[No Abstract] [Full Text] [Related]
13. [High demands on drug administration and pharmacological principles applied in ulcer diseases].
Hellström PM
Lakartidningen; 1991 Feb; 88(6):425-30. PubMed ID: 1671887
[No Abstract] [Full Text] [Related]
14. [Famotidine (quamatel) for treatment of ulcer disease].
Bogachev RS; Levina ZK
Khirurgiia (Mosk); 1999; (1):34. PubMed ID: 10050509
[No Abstract] [Full Text] [Related]
15. [Ulcer surgery and anti-ulcer agents. Changes in surgical activities and sale of anti-ulcer agents in Nord-Trøndelag 1975-89].
Haaverstad R; Moen OO; Kannelønning KS; Line PD; Wibe A; Bjerkeset T
Tidsskr Nor Laegeforen; 1994 Mar; 114(8):904-7. PubMed ID: 7910707
[TBL] [Abstract][Full Text] [Related]
16. [Famotidine. Pharmacologic and clinical profile of the new histamine H2 receptor antagonist].
Müller P; Dammann HG; Simon B
Fortschr Med; 1986 Apr; 104(15):319-22. PubMed ID: 2872147
[No Abstract] [Full Text] [Related]
17. Optimal therapeutic regimen of famotidine based on plasma concentrations in patients with chronic renal failure.
Hachisu T; Yokoyama T; Oda Y; Ando K; Hattori Y; Yoshida T
Clin Ther; 1988; 10(6):656-63. PubMed ID: 2905936
[TBL] [Abstract][Full Text] [Related]
18. [Ulfamid in the combined therapy of gastric and duodenal peptic ulcer].
Pal'tsev AI; Maslennikova TA
Ter Arkh; 1997; 69(2):62-3. PubMed ID: 9173582
[No Abstract] [Full Text] [Related]
19. The effects of intermittent and continuous intravenous infusion of famotidine on gastric acidity in patients with peptic ulcers.
Watanabe Y; Tsumura H; Sasaki H; Morimoto T
Clin Ther; 1990; 12(6):534-46. PubMed ID: 2289221
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of duodenal ulcer with famotidine. (Multicenter study)].
Bernal Sahagún F; Barinagarrementería AR; Barrera Ríos L; Briseño Velazco S; Casillas Romo A; Corral Medina A; De la Torre Bravo A; Díaz de León E; Díaz Seoane R; Gallo Reynoso S
Rev Gastroenterol Mex; 1989; 54(1):13-7. PubMed ID: 2667076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
